Versant Ventures VI GP-GP, LLC, 10% Owner at Akero Therapeutics, Inc. (AKRO), sold 89,284 shares at $19.73 ($1.8M) on 2020-01-15, disclosed to the SEC on 2020-01-15.
Open-market sale of $1.8M AKRO by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.10 | 19,343 | $389K | 21.7% |
| 2 | $20.10 | 19,343 | $389K | 21.7% |
| 3 | $20.16 | 11,593 | $234K | 13.1% |
| 4 | $20.16 | 11,593 | $234K | 13.1% |
| 5 | $20.84 | 83 | $2K | 0.1% |
| 6 | $20.00 | 12,307 |
| $246K |
| 13.8% |
| 7 | $19.73 | 7,511 | $148K | 8.3% |
| 8 | $19.73 | 7,511 | $148K | 8.3% |
| Total | $20.04 avg | 89,284 | $1.8M | 100% |
| Filing → |
| AKRO | SELL | 2020-01-09 | $2.1M | — | Filing → |
| AKRO | SELL | 2020-01-06 | $2.7M | — | Filing → |